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Abstract: The (trans)esterification reaction of bacterial biopolymers with a selected bioactive
compound with a hydroxyl group was applied as a convenient method for obtaining conjugates
of such compound. Tyrosol, a naturally occurring phenolic compound, was selected as a model of
a bioactive compound with a hydroxyl group. Selected biodegradable polyester and polyamide,
poly(3-hydroxybutyrate-co-4-hydroxybutyrate) (P(3HB-co-4HB)) and poly-γ-glutamic acid (γ-PGA),
respectively, were used. The (trans)esterification reactions were carried out in melt mediated by
4-toluenesulfonic acid monohydrate. The structures of (trans)esterification products were established
at the molecular level with the aid of ESI-MS2 (electrospray ionization tandem mass spectrometry)
and/or 1H NMR (nuclear magnetic resonance) techniques. Performed analyses confirmed that the
developed method leads to the formation of conjugates in which bioactive compounds are covalently
bonded to biopolymer chains. The amount of covalently bonded bioactive compounds in the resulting
conjugates depends on the type of biopolymers applied in synthesis.
Keywords: biodegradable polymers; polyhydroxyalkanoates; P(3HB-co-4HB); poly-γ-glutamic;
γ-PGA; conjugates; tyrosol; mass spectrometry
1. Introduction
Design of biodegradable delivery systems for bioactive substances is a rapidly developing field.
The aim of designing delivery systems is modification of properties of bioactive molecules, such
as solubility, stability and bioactivity, and improve the delivery efficiency. For these purposes
biodegradable, biocompatible and nontoxic polymeric carriers might be applied [1–4]. Potential
uses of polyhydroxyalkanoates (PHAs) in polymeric delivery systems of bioactive compounds have
been evaluated in a number of studies—for example, delivery systems for steroids [5], antibiotics [6,7],
or antitumor agents [8,9].
Polyhydroxyalkanoates are aliphatic polyesters produced under controlled conditions via
biotechnological processes using numerous microorganisms and by varying the producing strains and
substrates. The PHAs are accumulated as granules in the cell, reaching 90% levels of dry cell mass [10].
In this way, a number of polyesters which differ in monomer composition have been synthesized [11,12].
It was essential to search for different inexpensive raw materials for PHA production, and it is already
known that these biopolyesters can be produced from renewable resources and from a broad range of
waste and surplus materials, such as glycerol from biodiesel production, protein hydrolysates, meat
and bone meal from slaughtering and rendering industries or molasses from the sugar industry [13–15].
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Previously, we reported (i) one-pot synthesis in which the respective bioactive compound-
oligomer conjugates were obtained through the transesterification reaction of PHA biopolyesters
by selected bioactive compounds with a carboxyl group in the presence of 4-toluenesulfonic acid
monohydrate and (ii) a two-step procedure of obtaining bioactive PHA conjugates, designed for
bioactive compounds with hydroxyl group; in the first step, cyclic oligomers were obtained from
bacterial poly(3-hydroxybutyrate) according to the method described in the literature [16]; subsequent
lipase-catalyzed transesterification of the cyclic oligomers by the bioactive compounds leads to the
formation of the conjugates [17]. The proposed synthetic strategy for bioactive compounds with a
hydroxyl group is too complex and economically disadvantageous for industrial application. The
method of coupling of specific bioactive compounds (containing a hydroxyl group) to biodegradable
polymeric carriers has been presented. The elaborated method is a promising way of obtaining delivery
systems for retarded release of bioactive compounds. Our hypothesis was that the (trans)esterification
reaction of bacterial biopolymers with a bioactive compound with a hydroxyl group may prove to be a
more simple and economically favorable method for obtaining such conjugates.
Tyrosol was selected as a model of bioactive compound with a hydroxyl group. Tyrosol is a
naturally occurring phenolic compound found, for example, in olive oil and wine [18,19]. Tyrosol and
its derivatives show interesting biological properties, such as antioxidant [20] and anticancer effects [21]
as well as preventing inflammation-induced osteopenia [22] and smoking-induced oxidative stress [23].
The tyrosol-polymer conjugates were synthesized via (trans)esterification reaction of tyrosol
with selected biopolymers (such as poly(3-hydroxybutyrate-co-4-hydroxybutyrate) (P(3HB-co-4HB))
or poly-γ-glutamic acid (γ-PGA)) carried out in melt under an argon atmosphere mediated by
4-toluenesulfonic acid monohydrate (TSA¨H2O). To the best of our knowledge and according to
relevant information, there are no earlier reports on the use of the (trans)esterification method for the
synthesis of delivery systems of tyrosol based on such biopolymers.
2. Results
It was found that the “one-pot” transesterification method developed by us for obtaining
conjugates of bioactive compounds with the carboxyl group [17] could also be an implement for
preparing conjugates of bioactive compounds with a hydroxyl group.
The tyrosol-oligo(3HB-co-4HB) conjugates were synthesized via a transesterification reaction
of P(3HB-co-4HB) with tyrosol in the presence of TSA¨H2O (20 wt %) carried out in melt under an
argon atmosphere (Scheme 1). The results of the experiments performed are summarized in Table 1.
The amount of TSA¨H2O was chosen based on our previous experience, wherein the relationship
between the number average molar masses (Mn) of the resulting conjugates and the amount of
TSA¨H2O used in the process was experimentally determined [17]. In our previous research, it was
observed that increasing the quantity of water, which was introduced with TSA, led to the decrease of
the molar mass of resulting oligomers [17]. The optimal molar masses of the oligomers was obtained
by using of 20 wt % of TSA¨H2O; therefore, the amount of TSA¨H2O used in the each synthesis in
this study was the same and equaled the 20 wt %. From inspection of Table 1, it can be observed
that increasing the quantity of bioactive substance led to the decrease of molar mass of resulting
products. Moreover, based on these results (shown in Table 1), it was determined that the amount
of bioactive substance used in transesterification reactions influenced the dispersity index Mw/Mn.
Through increasing the amount of tyrosol, a decrease of dispersity index was achieved.
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studies were performed with the aid of ESI-MS (electrospray ionization mass spectrometry). 
Tyrosol-oligo(3HB-co-4HB) conjugates with number average molar masses in the range  
850–1800 g/mol were obtained. 
The 1H NMR spectrum of the products obtained through the transesterification reaction of 
P(3HB-co-4HB) with tyrosol mediated by TSA·H2O (Sample 2, Table 1) is presented in Figure 1. In 
this spectrum, signals corresponding to the protons of both comonomeric units were observed, 
signals labelled 1–3 correspond to the protons of the 3-hydroxybutyrate repeating units and signals 
labeled 4–5 correspond to the protons of the 4-hydroxybutyrate repeating units. The signals 
corresponding to the protons of the tyrosol molecule bonded to the oligomers were labeled 7–10, 
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Figure 1. The 1H NMR spectrum of Sample 2 from Table 1. 
Scheme 1. Transesterification reaction of P(3HB-co-4HB) by tyrosol, mediated by TSA¨ H2O. R = CH3,
x = 1–3HB units; R = H and x = 2–4HB units.
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Table 1. Results of the transesterification reaction of P(3-HB-co-4HB) by tyrosol in the presence of
4-toluenesulfonic acid monohydrate (TSA¨ H2O) (20 wt %).
Sample Tyrosol (wt %) Mn (g/mol) Mw/Mn
1 10 1800 3.16
2 20 1600 2.58
3 30 1000 2.11
4 40 850 1.87
5 50 950 1.76
The amount of tyrosol compared to the amount of biopolymer (0.25 g) used for the transesterification reactions,
expressed in weight percent. The Mn and Mw/Mn values were determined using GPC (gel permeation
chromatography). The Mn and Mw/Mn values for P(3-HB-co-4HB)biopolymer were equal Mn = 250,000 g/mol;
Mw/Mn = 2.5.
The structures of obtained conjugates were preliminarily characterized by GPC (gel permeation
chromatography) and 1H NMR techniques (results summarized in Table 1). Further structural
studies were performed with the aid of ESI-MS (electrospray ionization mass spectrometry).
Tyrosol-oligo(3HB-co-4HB) conjugates with number average molar masses in the range 850–1800 g/mol
were obtained.
The 1H NMR spectrum of the products obtained through the transesterification reaction of
P(3HB-co-4HB) with tyrosol mediated by TSA¨H2O (Sample 2, Table 1) is presented in Figure 1. In this
spectrum, signals corresponding to the protons of both comonomeric units were observed, signals
labelled 1–3 correspond to the protons of the 3-hydroxybutyrate repeating units and signals labeled 4–5
correspond to the protons of the 4-hydroxybutyrate repeating units. The signals corresponding to
the protons of the tyrosol molecule bonded to the oligomers were labeled 7–10, while signals of the
protons of the unbonded tyrosol molecule were labelled 7’–10’.
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In order to obtain more detailed structural information about the obtained conjugates,
the ESI-MSn technique was applied. Recently, ESI-MS has been successfully applied in the
structural studies of conjugates of biodegradable oligomers and bioactive substances, such as food
preservatives [24], herbicides [25,26], non-steroidal anti-inflammatory drugs [27,28], or antioxidants
used in cosmetology [29–31].
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The ESI-MS spectrum (in positive-ion mode) of the selected tyrosol-oligo(3HB-co-4HB) conjugate
(Sample 3, Table 1) is presented in Figure 2. The spectrum consists of singly charged ions. The main
series of ions correspond to sodium adduct of tyrosol-oligo(3HB-co-4HB) conjugates with tyrosol and
hydroxyl end groups. The additional series of signals (however, with significant lower intensity) visible
on the spectrum correspond to: sodium adduct of oligomers with hydroxyl and carboxyl end groups
(which formed due to the partial hydrolysis of biopolyesters), oligomers terminated by crotonate
and carboxyl end groups (formed due to the partial thermal degradation of biopolyesters), as well as
oligomers terminated by crotonate and tyrosol end groups which are the result of transesterification
between tyrosol and oligomers formed due to the partial thermal degradation of biopolyesters.
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Figure 2. ESI-MS spectrum in positive-ion mode of the tyrosol-oligo(3HB-co-4HB) conjugates obtained
by transesterification reaction between P(3HB-co-4HB) and tyrosol (for 3HB units R = CH3, x = 1,
for 4HB units R = H and x = 2).
In order to further structural clarification of tyrosol-oligo(3HB-co-4HB) bi conjugate structure
assignment (series A, Figure 2), tandem mas spectrometry (ESI-MS2) was used.
Figure 3 pr sents ESI-MS2 spectrum (in positive-ion mode) of the precursor ion at m/z 935
corresponds to adduct of tyros l- igo(3HB-co 4HB). Fragmentation of this ion, which proceeds
via β-hydrogen rearra gement at th ester groups, leads to th random b eakage of ster bonds along
the 3HB-co-4HB oligomer chain accompanied by an expulsion of neutral molecules nd to the creation
of product ions) (see scheme of Figur 3). According to the structures as igned the product ion at
m/z 831 corresponds t the oligomer formed by the loss of 3-hydroxybutyric acid (104 Da), the product
ion at m/z 815 corresponds to the oligomer formed by the loss of 4-ethenylphenol (120 Da), the product
ion at m/z 797 corresponds to the oligomer formed by the loss of tyrosol (138 Da) and the product
ion at m/z 729 c rresponds to the oligomer formed by the loss of 2-(4-hydr xyphenyl)et yl crotonate
206 Da)(see schem on Figure 3).
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Figure 3. ESI-MS/MS product ion spectrum of the sodiated tyrosol-oligo(3HB-co-4HB) conjugate at
m/z 935 and theoretical fragmentation pathway of this ion.
The conjugates of tyrosol and bacterial poly(3-hydroxybutyrate-co-4-hydroxybutyrate) described
above contain one bioactive molecule per oligomer chain. However, conjugate of bioactive compounds
with an increased amount of biologically active moieties along the oligomer chain seems to be
a much more interesting option. For the synthesis of such conjugates of poly-γ-glutamic acid
(γ-PGA), polymers made of D- or L-glutamic acid units connected by amide linkages [32], were
used as carriers. The γ-PGA is naturally occurring polymer that is also biodegradable, edible
and non-toxic toward humans and the environment, produced extracellularly by several species
of bacteria of the genus Bacillus classified as GRAS (Generally Regarded As Safe) by the US Food and
Drug Administration [33,34]. Poly-γ-glutamic acid has been already tested as a carrier for bioactive
substances, for example paclitaxel [35], cisplatin [36], insulin [37] and heparin [38].
For preparing conjugates of tyrosol and γ-PGA, similar procedures as for conjugates of
tyrosol-oligo(3HB-co-4HB) were applied. Esterification reactions were carried out in melt in the
presence of TSA¨H2O (20 wt %) (Scheme 2). Under these conditions, carboxyl groups along the γ-PGA
chain should undergo esterification with tyrosol molecules while peptide bonds along the polymer
chain could be hydrolyzed due to the presence of the water introduced.
It is known that, as a result of thermal degradation of polyamides, various products could be
obtained. Heating of polypeptides in the presence of water, leads to hydrolysis of peptide bonds [39].
The cis-eliminations are also known mechanisms of thermal decomposition of polyamides through a
6-membered ring which causes NH-CH2 bond scission and leads to oligomers with unsaturated alkyl
and amide end groups further transformed into nitriles [40–42]. Other known products of thermal
degradation are cyclic amides, which are result of intramolecular amide exchange [41–43].
Based on our previous results as well as other literature information we predicted that
esterification reaction of γ-PGA with tyrosol, which is carried out in melt, can lead to oligomer
with different structures. In order to obtain detailed structural information about obtained products,
i.e., the structures of the end groups and amount of repeating units in each conjugate oligomers,
the ESI-MS technique was used.
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Figure 4. ESI-MS spectrum (in positive-ion mode) of the tyrosol-γ-PGA conjugates obtained
by esterification reaction between γ-PGA and tyrosol (a) and spectral expansion in the range
m/z 840–1040 (b) and m/z 480–800 (c).
The presence of a tyrosole molecule in the obtained conjugate can be expected at each egree of
polymerization and the amount of this bioactive substance increases with an increase in the degree
of p lymerization. For xample, γ-PGA dime s can be bonded with a maximum f three bioactive
molecules due to presence of three carboxyl groups, while γ-PGA tetramer can be bonded for up to
five bioactive molecules due to the presence of five carboxyl groups.
From the i spection of mass sp ctrum (Figure 4), it can be observed that a hi her degree
of polymerization increases the number of possible structures of tyrosol-γ-PGA conjugates (see
Figure 4b,c).
The structures of the ions visible on the mass spectrum, which represent the γ-PGA oligomers
obtained in esterification carried out in melt, were assigned based on different mechanisms of thermal
decomposition of polyamides discussed in literature [40–44]. The proposed structures were placed in
Table 2.
Table 2. Structural assignments of the most intensive ions appearing in the expanded regions at m/z
480–800 and 840–1040 of the ESI–MS spectrum.
Structure Ions (m/z)
A
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In order to establish the structure of tyrosol-γ-PGA conjugates, ESI-MS2 analyses were performed
for selected molecules containing different amounts of bioactive molecule per oligomer chain. Figure 5
shows ESI-MS2 spectra of conjugates containing four bioactive molecules per oligomer chain.
Figure 5 presents ESI-MS2 spectrum (in positive-ion mode) of the precursor ion at m/z 1015
corresponding to γ-PGA oligomers containing four tyrosol molecules per one oligomer chain. One of
the possible structures of ion at m/z 1015 is shown on the scheme in Figure 5. The product ion at
m/z 997 corresponds to the oligomer formed by the loss of the water (18 Da). The product ion at
m/z 895 corresponds to the oligomer formed by the loss of the 4-ethenylphenol (120 Da). The product
ion at m/z 886 corresponds to the oligomer formed by the loss of the pyroglutamic acid, 5-membered
lactam (129 Da), from the N-terminal end. The product ion at m/z 877 corresponds to the oligomer
formed by the loss of the tyrosol (138 Da). The product ion at m/z 868 corresponds to the oligomer
formed by the loss of the γ-glutamic acid, 147 Da, (in cases when the last repeating unit is not esterified)
from C-terminal end.
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theoretical frag entation path ay of this ion.
The structural verification of the ions at m/z 1015 corresponding to tyrosol-γ-PGA oligomer
conjugates with the aid of ESI-MS2 techniques confirmed that those oligomers contained four tyrosole
units, which are covalently bonded to γ-PGA chains. Moreover, esterified carboxyl groups are
randomly distributed along the obtained conjugate chains.
3. Discussion
Previously, the two-step method for preparing conjugates of bioactive compound with a hydroxyl
group was reported by some of us. In the first step, cyclic oligomers of PHB (poly(3-hydroxybutyrate))
were obtained; in the second step, these cyclic oligomers were applied in transesterification reactions
with bioactive compounds in the presence of enzymes. The novel application of synthetic strategies
described here based on (trans)esterification of biopolymers with bioactive compounds with a hydroxyl
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group turned out to be a relatively quick, simple and solvent-free way of obtaining conjugates of
biopolymers with such bioactive compounds.
In this study, P(3HB-co-4HB) biopolymer was used to obtain conjugates with tyrosol via
transesterification reaction mediated by TSA¨H2O. Similarly, as was previously established, increasing
the quantity of water, which is introduced with TSA to the reaction medium, led to the decrease of
molar mass of resulting oligomers [17]. Moreover, based on results shown in Table 1, it was determined
that amount of bioactive substance used in transesterification reactions influenced the dispersity index
Mw/Mn. Through increasing the of amount of tyrosol, a decrease of dispersity index was achieved.
The transesterification of P(3HB-co-4HB) biopolyester with tyrosol leads to conjugates which
contain one bioactive molecule per oligomer chain. The poly-γ-glutamic acid is a polyamide which
contains carboxyl groups in each repeating unit, and these carboxyl groups allow for coupling bioactive
moieties to each repeating unit. Therefore, application of the γ-PGA, as a polymeric carrier provides a
possibility to increase the amount of biologically active moieties along the oligomer chain.
Applying γ-PGA in our study was successful and allowed us to obtain conjugates of bioactive
compounds with the γ-PGA oligomer chain. As was expected, the conjugates we synthesized contained
a higher amount of biologically active moieties distributed along the γ-PGA oligomer chain. The
amount of tyrosol molecules which are bonded to the γ-PGA oligomer chain increased with an increase
of molar masses of γ-PGA oligomers. For example, γ-PGA dimer can be bonded with a maximum of
three bioactive molecules due to the possibility of esterification by tyrosol of the three carboxyl groups
present in this oligomer, while γ-PGA tetramer can be bonded up to five bioactive molecules due to
presence of five carboxyl groups.
The tyrosol-γ-PGA conjugates were obtained in an esterification reaction between tyrosol and
γ-PGA biopolymer carried out in melt. Under these reaction conditions, the esterification between
tyrosol and γ-PGA biopolymer can be accompanied by thermal decomposition of γ-PGA, which
is typical for polyamides. The presence of tyrosol-γ-PGA conjugates with different structures
in the products of esterification reaction between tyrosol and γ-PGA was identified using mass
spectrometry. However, it is noteworthy that all types of obtained γ-PGA oligomers contain bioactive
molecules bonded along oligomer chains, which was confirmed using electrospray ionization tandem
mass spectrometry.
The structural characterization of the tyrosol-γ-PGA with the aid of ESI-MS2 techniques
allowed the structure of those conjugates at the molecular level to be established. Moreover, these
studies confirmed that esterified by tyrosol carboxyl groups are randomly distributed along γ-PGA
conjugate chains.
Determination of the most appropriate molar mass of tyrosol-oligo(3HB-co-4HB) and tyrosol-γ-
PGA conjugates, as well as the influence of the presence of various structures of the end groups in
tyrosol-γ-PGA conjugates on properties and potential applications of this conjugates as a delivery
system of tyrosol, will be investigated in further studies.
4. Materials and Methods
4.1. Materials
The poly(3-hydroxybutyrate-co-4-hydroxybutyrate) was purchased from Tianjin Green Bio-Science
(Tianjin, China); the number-average molar mass, as determined by GPC, was Mn = 250,000 g/mol and
the dispersity index was Mw/Mn = 2.5. The 4HB unit content was 8.8 mol % (based on the 1H NMR
spectrum). The poly-γ-glutamic acid was purchased from Natto Biosciences (Montreal, QC, Canada),
Mn = 47,800 g/mol, Mw/Mn = 3.2. Additionally, chloroform, hexane and N,N-Dimethylformamide
(DMF) were supplied by POCH SA (Gliwice, Poland). The 4-(2-hydroxyethyl)phenol (tyrosol) and
4-toluenesulfonic acid monohydrate were purchased from Sigma-Aldrich Chemie GmbH (Steinheim,
Germany). Dialysis membrane Spectra/Por (MWCO (molecular weight cut-off): 12,000–14,000) was
purchased from Carl Roth (Karlsruhe, Germany).
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4.2. Measurements
Gel permeation chromatography (GPC) analyses were carried out using Viscotek VE 1122 pump
(Malvern Instruments Ltd., Worcestershire, UK), Shodex SE-61 RI detector (JM Science Inc., Grand
Island, New York, NY, USA), and PLgel 3 µm MIXED-E (Polymer Laboratories, Santa Clara, CA, USA)
high-efficiency column (300 mm ˆ 7.5 mm). Analyses were performed at 35 ˝C using CHCl3 as mobile
phase with the 1 mL/min flow rate. The instrument was calibrated with polystyrene narrow standards.
Nuclear magnetic resonance (NMR) analyses were performed using NMR Spectrometer Avance II
600 MHz Ultrashield Plus (Bruker, Rheinstetten, Germany); CDCl3 was used as the solvent and
tetramethylsilane was used as the internal standard.
Electrospray mass spectrometry (ESI-MSn) analyses were performed in positive-ion mode using
a Thermo LCQ Fleet ion-trap mass spectrometer (Thermo Fisher Scientific Inc., San Jose, CA, USA).
Solutions of samples were introduced into the ESI source by continuous infusion at a 10 µL/min flow
rate using the instrument syringe pump. Settings and conditions: spray voltage: 5.0 kV, capillary
temperature: 200 ˝C, sheath gas: nitrogen, auxiliary gas: helium. For ESI-MS/MS experiments,
precursor ion was isolated by the ion trap and collisionally activated.
4.3. Synthesis of Conjugates
Biopolymer (0.25 g) and an appropriate amount of bioactive substance (amount of tyrosol for
synthesis of PHA-based conjugates is placed in Table 1; for synthesis of PGA-based conjugates 0.1 g
of tyrosol was used) and 4-toluenesulfonic acid monohydrate (TSA¨H2O) (0.05 g; 20 wt % compared
to biopolymer) were placed into a round bottom flask equipped with a magnetic stirring bar. The
vessel, containing reagents, was placed into a Heat-On Block System (RB Radley & Co. Ltd., Essex,
UK) located on a stirring hot plate. Reactions were carried out in the melt (at 167–172 ˝C) under an
argon atmosphere. The molten reagents were stirred for 90 s; then, the reaction mixture was cooled.
The PHA-based conjugates were purified by added 5 cm3 of chloroform and washed 5 times with
distilled water to remove any residual 4-toluenesulfonic acid. Then, the products were precipitated
with cold hexane and dried under a vacuum at room temperature. The PGA-based conjugates were
dissolved in DMF; solutions were dialyzed through a dialysis tubes for 72 h, precipitates settled at the
bottom of the dialysis bag. Precipitated products were dried under a vacuum at room temperature.
The yield of reactions was between 60% and 78%.
5. Conclusions
The method for the preparation of conjugates consisting of bioactive compounds with hydroxyl
group (tyrosol) and oligomers from bacterial biopolymers has been discussed in detail. The developed
method of (trans)esterification of selected biopolymers (such as P(3HB-co-4HB) or γ-PGA) in the
presence of tyrosol mediated by 4-toluenesulfonic acid monohydrate is occurring in melt. This one-pot
synthesis method is rapid and does not use solvents, and, therefore, is promising from a scale-up
perspective because of the relatively low cost of reagents and the rather simple procedure.
The structural characterization at the molecular level of the trans-esterification products with
the aid of ESI-MS2 and/or 1H NMR techniques confirmed that the developed method leads to the
formation of conjugates in which bioactive compounds are covalently bonded to biopolymer chains.
It was shown that transesterification of P(3HB-co-4HB) with tyrosol leads to the (3HB-co-4HB)
oligomers that contain one bioactive molecule covalently bonded to the oligomer chain, while
esterification of γ-PGA with tyrosol results in conjugates with increased amount of biologically
active moieties along the oligomer chain. Thus, unexpectedly, it was found that esterification reactions
of γ-PGA with tyrosol carried out in melt in the presence of TSA¨H2O enabled the preparation of
conjugates containing from one to seven bioactive molecule per oligomer chain, which was confirmed
using electrospray ionization tandem mass spectrometry. The signals in ESI mass spectrum correspond
to individual macromolecular ion of conjugates; therefore, based on the mass assignment of singly
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charged ions observed in the mass spectrum, we were able to established amount of repeating units in
each conjugate oligomers (degree of oligomerization) as well as amount of bioactive molecules per
oligomer chain.
The developed biodegradable polymeric systems should allow for the delivery of tyrosol, thereby
prolonging and improving the efficacy of this bioactive compound. The release of tyrosol should be
accompanied by the formation of non-toxic degradation products of P(3HB-co-4HB) or γ-PGA carriers.
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